本powerpoint演示首先简要概述内分泌干扰 化学品（EDC）和与EDC相关的美国监管问题。介绍了2004年EDC计划审查，以及关于MYP的费用问题（CQ）、小组委员会的调查结果和建议、2007年EDC计划 中期审查，2007年中期EDC计划审查 LTG1小组委员会收费问题（CQ）-了解科学 示例项目:低剂量效应、EDC混合物、暴露和风险管理、美国环境保护局（USEPA）内分泌干扰物 研究预算，2007年中期EDC项目审查 小组委员会的调查结果，增强美国环境保护局在 风险管理，根据《安全饮用水法案》（SDWA）对EDC进行监管，下一步- 2009年EDC项目回顾。包括桌子。

This powerpoint presentation begins by providing a brief overview of Endocrine Disrupting Chemicals (EDCs) and U.S. regulatory issues related to EDCs. The 2004 EDC Program Review is presented, along with charge questions (CQ) regarding MYP, subcommittee's findings and recommendations, the 2007 EDC Program Mid-Cycle Review, the 2007 Mid-Cycle EDC Program Review Charge Questions (CQ) for Subcommittee, LTG1 - Understand Science Example Project: Low-Dose Effects, Mixtures of EDCs, exposure and risk management, the U.S. Environmental Protection Agency (USEPA) Endocrine Disruptors Research Budget, the 2007 Mid-Cycle EDC Program Review Subcommittee's Findings, Enhance USEPA's Leadership in Risk Management, regulation of EDCs under the Safe Drinking Water Act (SDWA), Next Steps - 2009 EDC Program Review. Includes tables.